0001209191-16-142451.txt : 20160922
0001209191-16-142451.hdr.sgml : 20160922
20160922160954
ACCESSION NUMBER: 0001209191-16-142451
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160922
DATE AS OF CHANGE: 20160922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baird William D III
CENTRAL INDEX KEY: 0001547658
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 161897736
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-09-20
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001547658
Baird William D III
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
Chief Financial Officer
Common Stock
2016-09-20
4
M
0
3500
8.00
A
56450
D
Common Stock
2016-09-20
4
S
0
3500
8.00
D
52950
D
Common Stock
2016-09-20
4
S
0
17000
8.0044
D
35950
D
Stock Options (right to buy)
2.45
2016-09-20
4
M
0
3500
0.00
D
2015-01-03
2024-01-03
Common Stock
3500
34000
D
The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016
The sale of shares of common stock were made pursuant to a J.P. Morgan Securities LLC Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.04. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ William D. Baird, III
2016-09-22